Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation

Transfusion

Volumn 45, Issue 1, 2005, Pages 16-20

  Zupańska, Barbara ^a   Zaucha, J Maciej ^b   Michalewska, Bogumila ^b   Malinowska, Aniela ^b   Brojer, Ewa ^b   Hellmann, Andrzej ^b  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ANTIBODY; ANTIBODY DI; CYCLOSPORIN A; ERYTHROCYTE ANTIBODY; METHOTREXATE; UNCLASSIFIED DRUG;

ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; BLOOD SAMPLING; CASE REPORT; CHIMERA; CHRONIC MYELOID LEUKEMIA; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; GRAFT VERSUS HOST REACTION; HEMOLYSIS; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; SCREENING;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD GROUP ANTIGENS; BLOOD GROUPING AND CROSSMATCHING; ERYTHROCYTES; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; ISOANTIBODIES; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 12544250736     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.04104.x     Document Type: Article

References (26)

1. Myser T, Steedman M, Hunt K, et al. A bone marrow transplant with an acquired anti-Le(a): a case study. Hum Immunol 1986;17:102-6.
2. Ting A, Pun A, Dodds AJ, Atkinson K, Biggs JC. Red cell alloantibodies produced after bone marrow transplantation. Transfusion 1987;27:145-7.
3. Wernet D, Weiss B, Schmidt H, Northoff H. Antigen-independent reactivation of anti-E, years after allogeneic bone marrow transplantation: a case report. Br J Haematol 1995;91:758-60.
4. Abou-Elella AA, Camarillo TA, Allen MB, et al. Low incidence of red cell and HLA antibody formation by bone marrow transplant patients. Transfusion 1995;35:931-5.
5. Wernet D, Schnaidt M, Northoff H. Reactivation of recipient antibody to blood cell antigens soon after allogeneic bone marrow transplantation. Vox Sang 1996;71:212-5.
6. Lopez A, de la Rubia J, Arriaga F, et al. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant. Transfusion 1998;38:247-51.
7. Petz LD. Hemolysis associated with transplantation. Transfusion 1998;38:224-8.
8. Norol F, Bonin P, Charpentier F, et al. Apparent reactivation of a red cell alloantibody in a healthy individual after G-CSF administration. Br J Haematol 1998;103:256-8.
9. de La Rubia J, Arriaga F, Andreu R, et al. Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation: is ABO incompatibility a predisposing factor? Transfusion 2001;41:106-10.
10. Leo A, Mytilineos J, Voso MT, et al. Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti-Jk(a) after allogeneic PBPC transplantation. Transfusion 2000; 40:632-6.
11. Sokol RJ, Stamps R, Booker DJ, et al. Posttransplant immune-mediated hemolysis. Transfusion 2002;42:198-204.
12. Mijovic A. Alloimmunization to RhD antigen in RhD-incompatible haemopoietic cell transplants with non-myeloablative conditioning. Vox Sang 2002;83:358-62.
13. Franchini M, Gandini G, Aprili G. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004;33:1169-72.
14. Petz LD, Yam P, Wallace RB, et al. Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood 1987;70:1331-7.
15. Izumi N, Fuse I, Furukawa T, et al. Long-term production of pre-existing alloantibodies to E and c after allogenic BMT in a patient with aplastic anemia resulting in delayed hemolytic anemia. Transfusion 2003;43:241-5.
16. van Tol MJ, Gerritsen EJ, de Lange GG, et al. The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation. Blood 1996;87: 818-26.
17. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987;70:1382-8.
18. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986;314:729-35.
19. Pawlowski R, Maciejewska A. Forensic validation of a multiplex containing nine STRs-population genetics in northern Poland. Int J Legal Med 2000;114:45-9.
20. Byrne P. Use of a modified acid/EDTA elution technique. Immunohematology 1991;2:46-7.
21. Wu GG, Su YQ, Yu Q, Jin SZ, Zhao TM. Development of a DNA-based genotyping method for the Diego blood group system. Transfusion 2002;42:1553-6.
22. Girelli G, Arcese W, Blanchi A, et al. Hemolysis in Rh-negative female recipient after Rh-incompatible bone marrow transplantation for chronic myeloid leukemia. Haematologica 1986;71:46-9.
23. Mielcarek M, Leisenring W, Torok-Storb B, Storb R. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 2000;96:1150-6.
24. Daniels G. Human Blood Groups. 2nd ed. Boston: Blackwell Science; 2002.
25. Kusnierz-Alejska G, Bochenek S. Haemolytic disease of the newborn due to anti-Dia and incidence of the Dia antigen in Poland. Vox Sang 1992;62:124-6.
26. Lenkiewicz B, Zupanska B. The first example of anti-Diego(b) found in a Polish woman with the Di (a+b-) phenotype and haemolytic disease of the newborn not requiring treatment. Transfus Med 2003;13:161-3.